Letter to the editor in response to Tang et al.

Autor: Brown AL; The Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Abu-Arja MH; The Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Chintagumpala MM; The Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Paulino AC; The Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Nov 04; Vol. 26 (11), pp. 2154.

The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.

Autor: Abu-Arja MH; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Brown AL; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Su JM; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Okcu MF; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Lindsay HB; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cancer and Blood Disorders, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Denver, Colorado, USA., McGovern SL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McAleer MF; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Grosshans DR; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chintagumpala MM; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Paulino AC; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1912-1920.

A Novel Case of Concurrent T-cell and Early T-cell Precursor Lymphoblastic Lymphoma in an Adolescent Female.

Autor: Treinen C; Division of Hematology, Oncology, Blood and Marrow Transplant., Abu-Arja MH; Department of Pediatrics, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY., Kahwash SB; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital., Rangarajan HG; Division of Hematology, Oncology, Blood and Marrow Transplant.; Department of Pediatrics, The Ohio State University, Columbus, OH., Willen F; Division of Hematology, Oncology, Blood and Marrow Transplant., Audino AN; Division of Hematology, Oncology, Blood and Marrow Transplant.; Department of Pediatrics, The Ohio State University, Columbus, OH.

Publikováno v: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2022 Mar 01; Vol. 44 (2), pp. e550-e553.

Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.

Autor: Graham RT; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Division of Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Abu-Arja MH; Department of Pediatrics, New York-Presbyterian Brooklyn Methodist Hospital, Weill-Cornell College of Medicine, Brooklyn, New York, USA.; Division of Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA., Stanek JR; Division of Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio, USA., Cappellano A; Instituto de Oncologia Pediátrica GRAACC/UNIFESP, Division of Neuroncology, Sao Paulo, Brazil., Coleman C; Departments of Pediatrics, Neurology, and Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Chi S; Dana Farber/Boston Children's Cancer and Blood Disorder Center, Pediatric Neuro-Oncology, Boston, Massachusetts, USA., Cooney T; Dana Farber/Boston Children's Cancer and Blood Disorder Center, Pediatric Neuro-Oncology, Boston, Massachusetts, USA., Dhall G; Division of Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA., Ellen JG; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Finlay JL; Division of Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA., Fisher MJ; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Friedman GK; Division of Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA., Gajjar A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Gauvain K; Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri, USA., Hoffman LM; Division of Hematology/Oncology, Phoenix Children's Hospital, Phoenix, Arizona, USA., Hukin J; Division of Hematology and Oncology, Children's and Women's Health Centre of B.C., University of British Columbia, Vancouver, British Columbia, Canada., Lucas JT Jr; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Mueller S; Departments of Pediatrics, Neurology, and Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Navalkele P; Department of Pediatrics, SSM Cardinal Glennon Children's Hospital, Saint Louis University, Saint Louis, Missouri, USA., Ronsley R; Division of Hematology and Oncology, Children's and Women's Health Centre of B.C., University of British Columbia, Vancouver, British Columbia, Canada., Tinkle C; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Villeneuve S; Division of Hematology/Oncology, Izaak Walton Killam Hospital for Children, Halifax, Nova Scotia, Canada., Yeo KK; Dana Farber/Boston Children's Cancer and Blood Disorder Center, Pediatric Neuro-Oncology, Boston, Massachusetts, USA., Su JM; Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Margol A; Cancer and Blood Disease Institute and Division of Hematology-Oncology, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Gottardo NG; Department of Paediatric and Adolescent Oncology/Haematology, Perth Children's Hospital, Nedlands, Western Australia, Australia., Allen J; Department of Pediatrics, NYU Langone Health, New York, New York, USA., Packer R; Center for Neuroscience and Behavioral Medicine, Brain Tumor Institute, Children's National Health System, Washington, District of Columbia, USA., Bartels U; Division of Hematology/Oncology, Pediatric Neuro-Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Abdelbaki MS; Division of Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA.; Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Oct; Vol. 68 (10), pp. e29172. Date of Electronic Publication: 2021 Jun 14.

A Possible Case of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Newborn With Positive Placental In Situ Hybridization of SARS-CoV-2 RNA.

Autor: Alamar I; Department of Pediatrics, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, USA., Abu-Arja MH; Department of Pediatrics, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, USA., Heyman T; Department of Obstetrics and Gynecology, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, USA., Roberts DJ; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Desai N; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Narula P; Department of Pediatrics, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, USA., Dygulska B; Department of Pediatrics, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, USA.

Publikováno v: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2020 Nov 10; Vol. 9 (5), pp. 636-639.